Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41598-017-01160-1 http://scihub22266oqcxt.onion/10.1038/s41598-017-01160-1 C5430773!5430773!28432310     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Sci+Rep 2017 ; 7 (ä): ä Nephropedia Template TP {{tp|p=28432310|t=2017. Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis |pdf=|usr=}}{{28432310}} gab.com Text Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis JO: Sci Rep http://www.kidney.de/pget.php?&tw=1&pmid=28432310 #FOAvip Contrast-induced nephropathy (CIN) has become the third-leading cause of hospital-acquired acute renal injury. Although alprostadil has been proposed as an effective preventative measure, this conclusion remains inconsistent. Thus, we performed a meta-analysis of the published studies on this topic to evaluate the preventative effect of alprostadil on CIN. Databases, including PubMed, the Web of Science, Cochrane Library, Wanfang, the China Biological Medicine Database (SinoMed) and the China National Knowledge Infrastructure (CNKI) were systematically searched. Nineteen clinical trials involving 2267 individuals were identified. We utilized a random or a fixed effect model to calculate the pooled odd ratios (ORs) and the standardized mean differences (SMD), respectively. Compared to the control group, the CIN risk decreased significantly in the alprostadil group (P?<?0.00001, OR?=?0.29, 95% CI?=?0.21?0.39). In the subgroup of coronary angiography patients, the use of alprostadil also decreased the risk of CIN (P?<?0.00001, OR?=?0.27, 95% CI: 0.19?0.39). In conclusion, Alprostadil might be associated with a significant reduction in postcontrast Scr, BUN and CysC level and decrease the incidence of CIN. Twit Text FOAVip Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis ????Sci Rep http://www.kidney.de/pget.php?&tw=1&pmid=28432310 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28432310 #FOAvip English Wikipedia <ref>{{Cite pmid|28432310}}</ref> Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis #MMPMID28432310 Zhang JZ; Kang XJ; Gao Y; Zheng YY; Wu TT; Li L; Liu F; Yang YN; Li XM; Ma YT; Xie X Sci Rep 2017[]; 7 (ä): ä PMID28432310show ga Contrast-induced nephropathy (CIN) has become the third-leading cause of hospital-acquired acute renal injury. Although alprostadil has been proposed as an effective preventative measure, this conclusion remains inconsistent. Thus, we performed a meta-analysis of the published studies on this topic to evaluate the preventative effect of alprostadil on CIN. Databases, including PubMed, the Web of Science, Cochrane Library, Wanfang, the China Biological Medicine Database (SinoMed) and the China National Knowledge Infrastructure (CNKI) were systematically searched. Nineteen clinical trials involving 2267 individuals were identified. We utilized a random or a fixed effect model to calculate the pooled odd ratios (ORs) and the standardized mean differences (SMD), respectively. Compared to the control group, the CIN risk decreased significantly in the alprostadil group (P? äEfficacy of alprostadil for preventing of contrast-induced nephropathy(epmc).pdf DeepDyve Pubget Overpricing